Clinical and Economic Evaluation of Multidrug-Resistant Acinetobacter baumannii Colonization in the Intensive Care Unit
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background: The clinical and economic impact of multidrug-resistant (MDR) Acinetobacter baumannii colonization remains unclear. This study aimed to estimate and compare the mortality rates, length of stay (LOS), and hospitalization costs in the intensive care unit (ICU) for MDR A. baumannii colonized patients and a matched population. Materials and Methods: We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with MDR A. baumannii colonization with those of uncolonized subjects matched at the time they were admitted to the ICU between January 2012 and December 2014. Results: During the study period, 375 (7.5%) of the 4,779 patients were colonized with MDR A. baumannii. One hundred and twenty-two MDR A. baumannii colonized patients were compared with 122 uncolonized patients using propensity score matching. MDR A. baumannii colonized patients were likely to have a higher mortality rate compared to uncolonized patients (49.2% vs 32.0%; odds ratio [OR], 3.64). A longer ICU LOS and total admission days were observed in the MDR A. baumannii colonized patient group (4.14 and 4.67 days increase, OR 1.41 and 1.19). MDR A. baumannii colonization patients had an average extra ICU and total admission cost of $1,179 (₩1,261,334) and $1,333 (₩1,422,032) according to a multivariable regression model (OR, 1.27 and 1.17). Multivariable analysis identified the factors affecting ICU cost, which included, MDR A. baumannii colonization (OR = 1.33 ; P = 0.001), ICU LOS (OR = 1.97; P <0.001), valvular heart disease (OR = 1.12; P = 0.005), invasive devices (OR = 1.15; P = 0.018), and surgery (OR = 1.1; P <0.001). Conclusion: MDR A. baumannii colonization was associated with increased mortality, LOS, and costs in the ICU. A strict infection control program including preemptive isolation for high-risk groups would be helpful for reducing the burden of this infection.
Abstract
Background: The clinical and economic impact of multidrug-resistant (MDR) Acinetobacter baumannii colonization remains unclear. This study aimed to estimate and compare the mortality rates, length of stay (LOS), and hospitalization costs in the intensive care unit (ICU) for MDR A. baumannii colonized patients and a matched population. Materials and Methods: We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with MDR A. baumannii colonization with those of uncolonized subjects matched at the time they were admitted to the ICU between January 2012 and December 2014. Results: During the study period, 375 (7.5%) of the 4,779 patients were colonized with MDR A. baumannii. One hundred and twenty-two MDR A. baumannii colonized patients were compared with 122 uncolonized patients using propensity score matching. MDR A. baumannii colonized patients were likely to have a higher mortality rate compared to uncolonized patients (49.2% vs 32.0%; odds ratio [OR], 3.64). A longer ICU LOS and total admission days were observed in the MDR A. baumannii colonized patient group (4.14 and 4.67 days increase, OR 1.41 and 1.19). MDR A. baumannii colonization patients had an average extra ICU and total admission cost of $1,179 (₩1,261,334) and $1,333 (₩1,422,032) according to a multivariable regression model (OR, 1.27 and 1.17). Multivariable analysis identified the factors affecting ICU cost, which included, MDR A. baumannii colonization (OR = 1.33 ; P = 0.001), ICU LOS (OR = 1.97; P <0.001), valvular heart disease (OR = 1.12; P = 0.005), invasive devices (OR = 1.15; P = 0.018), and surgery (OR = 1.1; P <0.001). Conclusion: MDR A. baumannii colonization was associated with increased mortality, LOS, and costs in the ICU. A strict infection control program including preemptive isolation for high-risk groups would be helpful for reducing the burden of this infection.
참고문헌 (23)
- Holmberg SD, "Health and economic impacts of antimicrobial resistance", Rev Infect Dis, 9, pp.1065~1078 (1987)
- Howard A, "Acinetobacter baumannii: an emerging opportunistic pathogen", Virulence, 3, pp.243~250 (2012)
- Peleg AY, "Acinetobacter baumannii:emergence of a successful pathogen", Clin Microbiol Rev, 21, pp.538~582 (2008)
- Montefour K, "Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care", Crit Care Nurse, 28, pp.15~25 (2008)
- Young LS, "Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a sur-gical intensive care unit", Infect Control Hosp Epidemiol, 28, pp.1247~1254 (2007)
- 곽이경, "전국병원감염감시체계 중환자실 부문 결과 보고: 2009년 7월부터 2010년 6월", 병원감염관리, 16(1), pp.1~12 (2011), 대한의료관련감염관리학회
- Shinhye Cheon, "Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control", The Korean Journal of Internal Medicine, 31(2), pp.367~374 (2016), 대한내과학회[DOI]
- Jung E, "Vancomycin-resistant Enterococcus colonization in the intensive care unit:clinical outcomes and attributable costs of hospitalization", Am J Infect Control, 42, pp.1062~1066 (2014)
- Paterson DL, "The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species", Clin Infect Dis, 43(Suppl 2), pp.S43~S48 (2006)
- von Graevenitz A, "Manual of clinical microbiology", pp.520~532 (1995), American Society for Microbiology
- Clinical and Laboratory Standards Institute, "M7-A7, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically", CLSI, ~ (2006)
- Garnacho-Montero J, "Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings", Intensive Care Med, 31, pp.649~655 (2005)
- Luna CM, "Nosocomial Acinetobacter pneumonia", Respirology, 12, pp.787~791 (2007)
- Park YJ, "Survey on the infection control of multidrug-resistant microorganismsin general hospitals in Korea", Korean J Nosocomial Infect Control, 12, pp.112~121 (2007)
- Blot S, "Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization", Clin Infect Dis, 34, pp.1600~1606 (2002)
- Boyce JM, "Environmental contamination makes an important contribution to hospital infection", J Hosp Infect, 65(Suppl 2), pp.50~54 (2007)
- Dancer SJ, "The role of environmental cleaning in the control of hospital-acquired infection", J Hosp Infect, 73, pp.378~385 (2009)
- Weingarten CM, "Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital", Pharmacotherapy, 19, pp.1080~1085 (1999)
- García-Garmendia JL, "Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients", Crit Care Med, 27, pp.1794~1799 (1999)
- Rodríguez-Baño J, "Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle'' approach", Am J Infect Control, 37, pp.715~722 (2009)
- Muto CA, "SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus", Infect Control Hosp Epidemiol, 24, pp.362~386 (2003)
- Huskins WC, "Intervention to reduce transmission of resistant bacteria in intensive care", N Engl J Med, 364, pp.1407~1418 (2011)
- Weber SG, "Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force", Infect Control Hosp Epidemiol, 28, pp.249~260 (2007)